Central Venous Catheter As Peritoneal Indwelling Catheter for the Management of Recurrent Malignant Ascites: A Case Series

Overview

Journal Indian J Palliat Care

Specialty Critical Care

Date 2019 Mar 2

PMID 30820103

Citations 3

Authors

Brajesh Kumar Ratre

Praneeth Suvvari

Wasimul Hoda

Priodarshi Roychoudhury

Sachidanand Jee Bharti

Sushma Bhatnagar

Affiliations

Soon will be listed here.

Abstract

Background: Malignant ascites is an accumulation of fluid in the peritoneal cavity due to the manifestation of terminal metastatic malignancies. Accumulation of ascitic fluid could cause abdominal distention, early satiety, and shortness of breath. The onset and progression of these symptoms are not only distressing but also cause deterioration of the quality of life. Malignant ascites is associated with poor prognosis with anticipated life expectancy ranging from 1 to 4 months. Therapeutic paracentesis is the mainstay of palliation for malignant ascites. It only provides a temporary relief of symptoms, ascites re-accumulates, and paracentesis has to be repeated.

Objectives: The aim of this case series was to evaluate our experiences when treating malignant ascites with placement of central venous catheter in the peritoneal cavity, with special emphasis on patient satisfaction, comfort of caregiver, technical success, and adverse events.

Methods: Five patients with advanced disease and recurrent malignant ascites who required multiple paracentesis were selected for placement of 7-FG triple-port Central venous catheter in the peritoneal cavity. Maximum fluids that can be tapped were removed in ward. Patients and their relatives were assessed for satisfaction with the procedure.

Results: Out of 5 patients, 3 were female and 2 male (age between 46 and 62 years). Two patients had carcinoma gallbladder and one each of carcinoma ovary, breast, and prostate. All patients were followed up till 1 month from catheter placement. Patients and their relatives were well satisfied in terms of frequent hospital visit for paracentesis.

Conclusion: In summary, we suggest that central venous catheter may be used as indwelling peritoneal catheter for the symptom management of recurrent malignant ascites. It provides a relatively safe and cost-effective alternative to serial large-volume paracentesis that requires multiple hospital admissions.

Citing Articles

Drainage of ascites in cirrhosis.

Yang J, Peng Y, Zeng H, Lin X, Xu Z World J Hepatol. 2024; 16(9):1245-1257.

PMID: 39351514 PMC: 11438587. DOI: 10.4254/wjh.v16.i9.1245.

Management of Malignant Ascites by Indwelling Tunnelled Catheters in Indian Setup: A Case Series.

Suvvari P, Nair A, Mantha S, Saifuddin M, Naik V, Rayani B Indian J Palliat Care. 2021; 27(2):349-353.

PMID: 34511807 PMC: 8431247. DOI: 10.25259/IJPC_416_20.

Innovative Method to Deal with Pericatheter Leak in Home-based Management of Malignant Ascites.

Suvvari P, Nair A, Anne P, Rayani B Indian J Palliat Care. 2020; 26(3):394.

PMID: 33311888 PMC: 7725182. DOI: 10.4103/IJPC.IJPC_199_19.

References

Lee A, Lau T, Yeong K . Indwelling catheters for the management of malignant ascites. Support Care Cancer. 2000; 8(6):493-9. DOI: 10.1007/s005200000139. View

ONeill M, Weissleder R, Gervais D, Hahn P, Mueller P . Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol. 2001; 177(3):615-8. DOI: 10.2214/ajr.177.3.1770615. View

Enck R . Malignant ascites. Am J Hosp Palliat Care. 2002; 19(1):7-8. DOI: 10.1177/104990910201900101. View

Ye M, Pan H, Wang H, Lou F, Jin W, Zheng Y . Catheterization-associated complications of intraperitoneal chemotherapy in advanced gastric cancer. World J Gastroenterol. 2004; 10(9):1372-4. PMC: 4622787. DOI: 10.3748/wjg.v10.i9.1372. View

Coll S, Vila M, Molina L, Gimenez M, Guarner C, Sola R . Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction. Eur J Gastroenterol Hepatol. 2004; 16(3):347-53. DOI: 10.1097/00042737-200403000-00016. View

Rosenberg S, Courtney A, Nemcek Jr A, Omary R . Comparison of percutaneous management techniques for recurrent malignant ascites. J Vasc Interv Radiol. 2004; 15(10):1129-31. DOI: 10.1097/01.RVI.0000136828.42612.B4. View

Becker G, Galandi D, Blum H . Malignant ascites: systematic review and guideline for treatment. Eur J Cancer. 2006; 42(5):589-97. DOI: 10.1016/j.ejca.2005.11.018. View

Rosenberg S . Palliation of malignant ascites. Gastroenterol Clin North Am. 2006; 35(1):189-99, xi. DOI: 10.1016/j.gtc.2005.12.006. View

Mercadante S, Intravaia G, Ferrera P, Villari P, David F . Peritoneal catheter for continuous drainage of ascites in advanced cancer patients. Support Care Cancer. 2008; 16(8):975-8. DOI: 10.1007/s00520-008-0453-x. View

10.

Courtney A, Nemcek Jr A, Rosenberg S, Tutton S, Darcy M, Gordon G . Prospective evaluation of the PleurX catheter when used to treat recurrent ascites associated with malignancy. J Vasc Interv Radiol. 2008; 19(12):1723-31. DOI: 10.1016/j.jvir.2008.09.002. View

11.

Saif M, Siddiqui I, Sohail M . Management of ascites due to gastrointestinal malignancy. Ann Saudi Med. 2009; 29(5):369-77. PMC: 3290049. DOI: 10.4103/0256-4947.55167. View

12.

White J, Carolan-Rees G . PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites: a NICE Medical Technology Guidance. Appl Health Econ Health Policy. 2012; 10(5):299-308. DOI: 10.1007/BF03261864. View

13.

Agah S, Tavakoli S, Nikbakht H, Najafi M, Al-Agha A . Central venous pressure catheter for large-volume paracentesis in refractory ascites. Indian J Gastroenterol. 2014; 33(4):310-5. DOI: 10.1007/s12664-014-0448-0. View

14.

Stukan M, Lesniewski-Kmak K, Wroblewska M, Dudziak M . Management of symptomatic ascites and post-operative lymphocysts with an easy-to-use, patient-controlled, vascular catheter. Gynecol Oncol. 2014; 136(3):466-71. DOI: 10.1016/j.ygyno.2014.11.073. View

15.

Meier M, Mortensen F, Torp Madsen H . Malignant ascites in patients with terminal cancer is effectively treated with permanent peritoneal catheter. Acta Radiol Open. 2015; 4(7):2058460115579934. PMC: 4548747. DOI: 10.1177/2058460115579934. View

16.

Gu X, Zhang Y, Cheng M, Liu M, Zhang Z, Cheng W . Management of non-ovarian cancer malignant ascites through indwelling catheter drainage. BMC Palliat Care. 2016; 15:44. PMC: 4839130. DOI: 10.1186/s12904-016-0116-5. View

17.

Sudulagunta S, Sodalagunta M, Bangalore Raja S, Khorram H, Sepehrar M, Noroozpour Z . Clinical Profile and Complications of Paracentesis in Refractory Ascites Patients With Cirrhosis. Gastroenterology Res. 2015; 8(3-4):228-233. PMC: 5040531. DOI: 10.14740/gr661w. View

18.

Lacy J, Wieman T, Shively E . Management of malignant ascites. Surg Gynecol Obstet. 1984; 159(4):397-412. View

19.

Po C, Bloom E, Mischler L, Raja R . Home ascites drainage using a permanent Tenckhoff catheter. Adv Perit Dial. 1996; 12:235-6. View

20.

Lee C, Bociek G, Faught W . A survey of practice in management of malignant ascites. J Pain Symptom Manage. 1998; 16(2):96-101. DOI: 10.1016/s0885-3924(98)00037-2. View